Validation Study of G4 User Interface
NCT01142895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33
Last updated 2010-06-11
Summary
The purpose of this simulated useability study is to demonstrate the user interface and software design mitigate potential safety concerns.
Conditions
Sponsors & Collaborators
-
Tandem Diabetes Care, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2010-05-31
More Related Trials
-
InPen User Experience
NCT05029271 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Verify Effect of Smartpen Coordinated With Glucose Sensor.
NCT06310980 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study
NCT05014789 ·Status: COMPLETED ·Phase: NA
-
Insulin Titration System Based on Deep Learning
NCT05409391 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy and Safety of Insulin Glargine Injected by Needle-free Jet Syringe
NCT04093284 ·Status: UNKNOWN ·Phase: NA
-
Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness
NCT00530023 ·Status: COMPLETED ·Phase: PHASE4
-
Web-Based Simulation Tool For Self-Management Support In Type 1 Diabetes Mellitus
NCT04439903 ·Status: COMPLETED ·Phase: NA
-
An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor
NCT01112696 ·Status: COMPLETED ·Phase: NA
-
Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)
NCT05422053 ·Status: COMPLETED ·Phase: NA
-
A Pilot Test of t:Slim X2 With Control-IQ Technology
NCT03368937 ·Status: COMPLETED ·Phase: NA
-
Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue for the Treatment of Type-1 Diabetic Patients
NCT00812591 ·Status: COMPLETED ·Phase: NA
-
Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4
NCT01775059 ·Status: UNKNOWN ·Phase: NA
-
Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes
NCT04617795 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study - Integrated Sensor and Infusion Set. Trial III
NCT01773668 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults with Type-1 Diabetes Mellitus
NCT06097689 ·Status: COMPLETED ·Phase: NA
-
Tandem Freedom Feasibility Study 1
NCT06428591 ·Status: COMPLETED ·Phase: NA
-
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
NCT02003898 ·Status: COMPLETED ·Phase: NA
-
Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial
NCT03195140 ·Status: COMPLETED ·Phase: NA
-
TAK-329 Glucose Clamp Study
NCT01311076 ·Status: COMPLETED ·Phase: PHASE1
-
Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study
NCT02877771 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
NCT04084171 ·Status: COMPLETED ·Phase: NA
-
Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software
NCT00552734 ·Status: COMPLETED
-
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
NCT00441129 ·Status: COMPLETED ·Phase: NA
-
A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes
NCT05785832 ·Status: COMPLETED ·Phase: NA
-
Transdermally Delivered Human Insulin Product
NCT03544996 ·Status: COMPLETED